The clinical significance of non-criteria antiphospholipid antibodies in atypical antiphospholipid syndrome
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Yue Xiong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Abortion, Habitual. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Gusu Health Talent Research Project, Medical Innovation Application of Suzhou Science and Technology Bureau, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To analyse the correlation between non-criteria antiphospholipid antibodies (non-criteria aPLs) and clinical symptoms (recurrent miscarriage) in patients with seronegative antiphospholipid syndrome (SNAPS).
Methods
Ninety-four SNAPS patients who were treated in the First Affiliated Hospital of Soochow University from May 2022 to May 2024 were included. Chemiluminescence immunoassay was used to detect anti-β2 glycoprotein I antibody, anti-cardiolipin antibody, and lupus anticoagulant. Enzyme-Linked Immunosorbent Assay (ELISA) was used to detect the levels of anti-annexin A5 (ANXA5), anti-phosphatidylethanolamine antibody (aPE), anti-prothrombin Immunoglobulin G (IgG) antibody (aPT IgG), anti-prothrombin Immunoglobulin M (IgM) antibody (aPT IgM), anti-phosphatidylserine/prothrombin IgG antibody, and anti-phosphatidylserine/prothrombin IgM antibody. The correlation between non-criteria aPLs and clinical events was analysed.
Results
Compared with the non-criteria antibody-negative group, the positive group had a higher rate of positive antinuclear antibodies (P < .05). The proportion of recurrent miscarriage in the positive non-criteria antibody group was significantly higher than in the negative group (P = .002). Compared with the negative group, patients with positive ANXA5 antibody and aPT IgM were more likely to have recurrent miscarriage (P < .05). Compared with the aPE-negative group, those with aPE-positive were more likely to experience early miscarriage (P = .039). Both aPT IgM subtype (P = .004) and ANXA5 (P = .013) antibodies were the risk factors for recurrent miscarriage. Patients with positive ANXA5, anti-prothrombin IgG, and aPT/PS IgM antibodies showed a significant decrease in antibody titers after treatment (P < .05).
Conclusions
Detection of non-criteria aPLs contributes to improving the diagnosis of SNAPS, assessing its development trends, and intervening promptly to prevent recurrent miscarriage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Förderung
- Gusu Health Talent Research Project
- Medical Innovation Application of Suzhou Science and Technology Bureau
- National Natural Science Foundation of China
Zitieren
APA
Xiong, Y., Wu, T., Wang, L., Shen, X., Yin, Y., Wu, J., Ren, T., Cao, J., Cheng, T., & Wang, M. (2025). The clinical significance of non-criteria antiphospholipid antibodies in atypical antiphospholipid syndrome. Modern Rheumatology. https://doi.org/10.1093/mr/roaf060
Vancouver
Xiong Y, Wu T, Wang L, Shen X, Yin Y, Wu J, et al. The clinical significance of non-criteria antiphospholipid antibodies in atypical antiphospholipid syndrome. Modern Rheumatology. 2025. doi:10.1093/mr/roaf060
BibTeX
@article{Xiong2025,
author = {Xiong, Yue and Wu, Tingting and Wang, Lei and Shen, Xinyi and Yin, Yufeng and Wu, Jian and Ren, Tian and Cao, Jing and Cheng, Tao and Wang, Mingjun},
title = {The clinical significance of non-criteria antiphospholipid antibodies in atypical antiphospholipid syndrome},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf060}
}
EUVIMED